Johnson and johnson
Congo to start using J&J Ebola vaccine in November
The J&J vaccine will complement another vaccine manufactured by Merck, which has been administered to more than 225,000 people.
-
Johnson & Johnson must pay $8bn over drug side effect - jury
Johnson & Johnson and its subsidiary Janssen Pharmaceuticals were blamed as plaintiff Nicholas Murray told the Philadelphia court that the drug Risperdal, prescribed to treat schizophrenia and bipolar disorder, had made him grow breasts.
-
J&J liable for $572 million in Oklahoma opioid epidemic trial; shares rise
The state’s attorney general had filed the lawsuit, seeking $17 billion to address the impact of the drug crisis on Oklahoma.
-
Johnson & Johnson says Indian drug regulators visited facilities, took samples
The visits came as a probe is launched into J&J’s Baby Powder following a report that the firm knew that cancer-causing asbestos could be found in the product.
-
Johnson & Johnson ordered to pay $55m in talc-powder trial
A woman claimed using J&Js talc-powder for feminine hygiene caused her to develop ovarian cancer.
-
Atteridgeville clinic launched to empower black nurses
Unjani Clinics NPC launched a partnership with billion dollar pharmaceutical company, Johnson and Johnson.
-
No guarantee verdict against Johnson & Johnson will impact future cases
Johnson & Johnson lost a case after it was heard in court that its talc powder was linked to ovarian cancer.
